Blockbuster weight loss drug Ozempic could get cheaper by 2027, as it's on the list of medications the government is ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

As a result of the disappointing results, Boehringer said that it was abandoning a long-term extension trial called CONNEX-X, ...

The new first-line MCL indication gives Calquence a slice of the market of its own and could spur further growth of the drug, ...